NCT06722066View on ClinicalTrials.gov

Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: SAINT-TAVR Calcium Registry

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 2, 2024

Primary Completion Date

December 2, 2031

Study Completion Date

October 2, 2034

Conditions
Aortic Stenosis
Interventions
DEVICE

Transcatheter aortic valve replacement with ballon-expandable or self-expandable valves

Device: Edwards SAPIEN 3 valve, Medtronic Evolut valve, Boston Acurate Neo valve, or Abbott Navitor Access route: transfemorak, subclavian, transapical, transcarotid, or transcaval The use of balloon dilation will be left to the discretion of the operator.

Trial Locations (1)

122-200

RECRUITING

Division of Cardiology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul

All Listed Sponsors
lead

Eunpyeong St. Mary's Hospital

OTHER